TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.340nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.350nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.360nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.360nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.370nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.370nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.390nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.410nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.440nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.460nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.490nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.5nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.510nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.510nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.520nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.560nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.660nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
TargetReceptor-type tyrosine-protein kinase FLT3(Homo sapiens (Human))
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd.
US Patent
Affinity DataIC50: 0.720nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair